ISSCR Supports Amendment in U.S. Congress to Prevent Fetal Tissue Research Funding Restrictions

The ISSCR and other medical, scientific, educational, and healthcare groups sent a letter to members of the U.S. Congress supporting an amendment that would prevent the implementation of a new policy that would impose substantial barriers for fetal tissue research.

We were pleased to see the amendment pass in the U.S. House of Representatives on 13 June, 2019, as reported in The Washington Post.

The ISSCR opposes the restrictions on fetal tissue research funding, noting that ethical standards for fetal tissue research have been in place for decades, with bipartisan support in the U.S. Congress.

Previous
Previous

The ISSCR Announces Establishment of Lawrence Goldstein Science Policy Fellowship

Next
Next

ISSCR Applauds Landmark Court Ruling in Favor of FDA Regulating Stem Cell Therapies Offered by Florida Clinic